Global Spinal Implants Market is expected to reach USD 14.0 billion by 2022, from USD 9.6 billion in 2015, growing at a CAGR of 5.5% during the forecast period of 2016 to 2022.
Global Spinal Implants Market is segmented based on product type, surgery type, procedure type, end-user and geography.
On the basis of product type the market is further segmnented into spinal fusion, vertebral compression fracture treatment devices and spinal non-fusion. The spinal fusion segment is divided into cervical fusion and thoraco-lumbar fusion. The spinal non-fusion devices market is segmented on the basis of product types into dynamic stabilization devices, artificial discs, annulus repair devices and nuclear disc prosthesis.
For Sample Report: Global Spinal Implants Market – Trends and Forecast to 2022
Based on procedure type the market is further segmented into open surgery and minimally invasive surgeries.On the basis procedure type the market is segmented into discectomy, laminectomy, foraminectomy, facetectomy, corpectomy among others.
Based on end-users the market is further segmented into Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others.
Based on geography the market covers data reports for geographical regions, North America, Europe, Asia-Pacific, Middle East and Africa, South America and Rest of the World. North America is the largest market and Asia-Pacific growing market in the forecast years. The report of this market are further segmented into U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.
To read more about the scope and findings of this report visit: Global Spinal Implants Market is poised to reach USD 14.0 billion by 2022
On the basis of application the market is segmented into orthopedic, ENT, neurosurgery dental and others.
Based on end-users the Surgical Navigation Systems and Software market is segmented into hospitals and ambulatory surgical centers.
Based on geography the Surgical Navigation Systems and Software market is segmented into North & South America, Europe, Asia-Pacific and, Middle East & Africa. The report of this market shares countries such as U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among other companies.
KEY PLAYERS OPERATING IN GLOBAL SPINAL IMPLANTS MARKET:
- Zimmer Inc.
- DepuySynthes Companies
- Stryker
- Benvenue Medical
- CareFusion Corporation
- Medtronic
- Alphatec Spine, Inc.
- NuVasive Inc.
- Integra Lifesciences Holdings Corporation
- Orthofix International N.V.
- Globus Medical Inc.
- LDR Holding Corporation
- K2M Inc.
- B. Braun Melsungen.
To Browse Full Report and Pricing: Global Spinal Implants Market – Trends and Forecast to 2022
Table of Contents:
1 INTRODUCTION
1.1. OVERVIEW OF THE SPINAL IMPLANTS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL SPINAL IMPLANTS MARKET
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. EPIDEMIOLOGY DATA FORECASTING MODEL
2.4. GLOBAL SPINAL IMPLANTS MARKET: RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL SPINAL IMPLANTS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 SPINAL IMPLANTS MARKET, EPIDEMIOLOGY STUDIES
5.1. OVERVIEW
5.2. TOTAL NUMBER OF SPINAL PROCEDURES PERFORMED; (2010 – 2025)
5.2.1. NORTH AMERICA, BY COUNTRY
5.2.2. EUROPE, BY COUNTRY
5.2.3. ASIA-PACIFIC, BY COUNTRY
5.2.4. REST OF THE WORLD, BY COUNTRY
5.2.5. SOURCES BIBLIOGRAPHY
5.3. PREVALENT POPULATION OF OSTEOPOROSIS: (2010 – 2025)
5.3.1. NORTH AMERICA, BY COUNTRY
5.3.2. EUROPE, BY COUNTRY
5.3.3. ASIA-PACIFIC, BY COUNTRY
5.3.4. REST OF THE WORLD, BY COUNTRY
5.3.5. SOURCES BIBLIOGRAPHY
5.4. PREVALENT POPULATION OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS OF SPINE; (2010 – 2025)
5.4.1. NORTH AMERICA, BY COUNTRY
5.4.2. EUROPE, BY COUNTRY
5.4.3. ASIA-PACIFIC, BY COUNTRY
5.4.4. REST OF THE WORLD, BY COUNTRY
5.4.5. SOURCES BIBLIOGRAPHY
5.5. PREVALENT POPULATION OF SPINAL STENOSIS; (2010 – 2025)
5.5.1. NORTH AMERICA, BY COUNTRY
5.5.2. EUROPE, BY COUNTRY
5.5.3. ASIA-PACIFIC, BY COUNTRY
5.5.4. REST OF THE WORLD, BY COUNTRY
5.5.5. SOURCES BIBLIOGRAPHY
5.6. PREVALENT POPULATION OF SCOLIOSIS; (2010 – 2025)
5.6.1. NORTH AMERICA, BY COUNTRY
5.6.2. EUROPE, BY COUNTRY
5.6.3. ASIA-PACIFIC, BY COUNTRY
5.6.4. REST OF THE WORLD, BY COUNTRY
5.6.5. SOURCES BIBLIOGRAPHY
5.7. PREVALENT POPULATION OF DEGENERATIVE DISK DISEASE; (2010 – 2025)
5.7.1. NORTH AMERICA, BY COUNTRY
5.7.2. EUROPE, BY COUNTRY
5.7.3. ASIA-PACIFIC, BY COUNTRY
5.7.4. REST OF THE WORLD, BY COUNTRY
5.7.5. SOURCES BIBLIOGRAPHY
6 SPINAL IMPLANTS MARKET, BY COMPETITIVE MARKET ASSESMENT
6.1. OVERVIEW
6.2. SPINAL IMPLANTS VS SPINE BIOLOGIS
6.3. FUSION VS NON-FUSION SURGERIES
6.4. UPCOMING TECHNOLOGIES IN SPINE SURGERIES
7 SPINAL IMPLANTS MARKET, BY PRODUCT TYPE
7.1. OVERVIEW
7.2. SPINAL FUSION DEVICES (2014 – 2022)
7.2.1. CERVICAL FUSION DEVICES, BY PRODUCT TYPE
7.2.1.1. ANTERIOR CERVICAL FUSION, PRODUCT TYPE
7.2.1.1.1. ANTERIOR CERVICAL PLATES (2014 – 2022)
7.2.1.1.1.1. ONE LEVEL (2014 – 2022)
7.2.1.1.1.2. TWO LEVEL (2014 – 2022)
7.2.1.1.1.3. THREE LEVEL (2014 – 2022)
7.2.1.1.2. CERVICAL INTERBODY DEVICES (2014 – 2022)
7.2.1.2. POSTERIOR CERVICAL FUSION (2014 – 2022)
7.2.2. THORACO LUMBAR INTERBODY FUSION (LIF) DEVICES, BY PRODUCT TYPE
7.2.2.1. ANTERIOR INTERBODY (ALIF) (2014 – 2022)
7.2.2.2. POSTERIOR INTERBODY (PLIF) (2014 – 2022)
7.2.2.3. TRANSFORAMINAL INTERBODY (TLIF) (2014 – 2022)
7.2.2.4. AXIAL LUMBAR INTERBODY (AXIALIF) (2014 – 2022)
7.3. SPINAL NON-FUSION DEVICES, BY PRODUCT TYPE
7.3.1. DYNAMIC STABILIZATION DEVICES, BY PRODUCT TYPE
7.3.1.1. INTERSPINOUS DECOMPRESSION SPACERS (2014 – 2022)
7.3.1.2. PEDICLE SCREW SYSTEMS (2014 – 2022)
7.3.2. ARTIFICIAL DISCS, BY PRODUCT TYPE
7.3.2.1. ARTIFICIAL CERVICAL DISCS (2014 – 2022)
7.3.2.2. ARTIFICIAL LUMBAR DISCS (2014 – 2022)
7.3.3. OTHERS
7.4. VERTEBRAL COMPRESSION FRACTURE (VCF) TREATMENT DEVICES, BY PRODUCT TYPE
7.4.1. BALOON KYPHOPLASTY DEVICES (2014 – 2022)
7.4.2. VERTEBOPLASTY DEVICES (2014 – 2022)
8 SPINAL IMPLANTS MARKET, BY PROCEDURE TYPE
8.1. OVERVIEW
8.2. MINIMALLY INVASIVE SURGERIES (2014 – 2022)
8.3. OPEN END SURGERY (2014 – 2022)
9 SPINAL IMPLANTS MARKET, BY END-USER
9.1. OVERVIEW
9.2. HOSPITALS (2014 – 2022)
9.3. SPINAL SURGERY CENTERS (2014 – 2022)
9.4. ORTHOPEDIC CLINICS AND OFFICES (2014 – 2022)
9.5. OTHERS (2014 – 2022)
10 SPINAL IMPLANTS MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE SPINAL IMPLANTS MARKET, (2014 – 2022)
(ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY) (MARKET VALUE (USD MILLION))
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.10. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. SOUTH AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF SOUTH AMERICA
10.1.5. MIDDLE EAST AND AFRICA (MEA)
10.1.5.1. SOUTH AFRICA
10.1.5.2. SAUDI ARABIA
10.1.5.3. UNITED ARAB EMIRATES (U.A.E)
10.1.5.4. REST OF MEA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11 SPINAL IMPLANTS MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL SPINAL IMPLANTS MARKET: COMPANY SHARE ANALYSIS
11.2. U.S. SPINAL IMPLANTS MARKET: COMPANY SHARE ANALYSIS
11.3. EUROPE SPINAL IMPLANTS MARKET: COMPANY SHARE ANALYSIS
11.4. ASIA-PACIFIC SPINAL IMPLANTS MARKET: COMPANY SHARE ANALYSIS
11.5. SOUTH AMERICA SPINAL IMPLANTS MARKET: COMPANY SHARE ANALYSIS
11.6. MERGERS & ACQUISITIONS
11.7. NEW PRODUCT DEVELOPMENT & APPROVALS
11.8. REGULATORY CHANGES
12 SPINAL IMPLANTS MARKET, COMPANY PROFILES
12.1 ZIMMER BIOMET
12.1.1 OVERVIEW
12.1.2 SWOT ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.2 DEPUYSYNTHES COMPANIES
12.2.1 OVERVIEW
12.2.2 SWOT ANALYSIS
12.2.3 PRODUCT PORTFOLIO
12.2.4 REVENUE ANALYSIS
12.2.5 ANALYSTS VIEW
12.3 STRYKER
12.3.1 OVERVIEW
12.3.2 SWOT ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 REVENUE ANALYSIS
12.3.5 ANALYST VIEW
12.4 BENVENUE MEDICAL
12.4.1 OVERVIEW
12.4.2 SWOT ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 REVENUE ANALYSIS
12.4.5 ANALYSTS VIEW
12.5 CAREFUSION CORPORATION
12.5.1 OVERVIEW
12.5.2 SWOT ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 REVENUE ANALYSIS
12.5.5 ANALYSTS VIEW
12.6 MEDTRONIC
12.6.1 OVERVIEW
12.6.2 SWOT ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 REVENUE ANALYSIS
12.6.5 ANALYSTS VIEW
12.7 ALPHATEC SPINE, INC.
12.7.1 OVERVIEW
12.7.2 SWOT ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 REVENUE ANALYSIS
12.7.5 ANALYSTS VIEW
12.8 NUVASIVE, INC.
12.8.1 OVERVIEW
12.8.2 SWOT ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 REVENUE ANALYSIS
12.8.5 ANALYSTS VIEW
12.9 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
12.9.1 OVERVIEW
12.9.2 SWOT ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 REVENUE ANALYSIS
12.9.5 ANALYSTS VIEW
12.10 ORTHOFIX HOLDINGS, INC.
12.10.1 OVERVIEW
12.10.2 SWOT ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 REVENUE ANALYSIS
12.10.5 ANALYSTS VIEW
12.11 GLOBUS MEDICAL, INC.
12.11.1 OVERVIEW
12.11.2 SWOT ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 REVENUE ANALYSIS
12.11.5 ANALYSTS VIEW
12.12 LDR HOLDINGS CORPORATION
12.12.1 OVERVIEW
12.12.2 SWOT ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 REVENUE ANALYSIS
12.12.5 ANALYSTS VIEW
12.13 K2M, INC.
12.13.1 OVERVIEW
12.13.2 SWOT ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 REVENUE ANALYSIS
12.13.5 ANALYSTS VIEW
12.14 B.BRAUN MELSUNGEN AG
12.14.1 OVERVIEW
12.14.2 SWOT ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 REVENUE ANALYSIS
12.14.5 ANALYSTS VIEW
12.15 ULRICH GMBH & CO.KG
12.15.1 OVERVIEW
12.15.2 SWOT ANALYSIS
12.15.3 PRODUCT PORTFOLIO
12.15.4 REVENUE ANALYSIS
12.15.5 ANALYSTS VIEW
12.16 TITAN SPINE
12.16.1 OVERVIEW
12.16.2 SWOT ANALYSIS
12.16.3 PRODUCT PORTFOLIO
12.16.4 REVENUE ANALYSIS
12.16.5 ANALYSTS VIEW
12.17 AURORA SPINE, INC.
12.17.1 OVERVIEW
12.17.2 SWOT ANALYSIS
12.17.3 PRODUCT PORTFOLIO
12.17.4 REVENUE ANALYSIS
12.17.5 ANALYSTS VIEW
12.18 SIGNUS MEDIZINTECHNIK GMBH
12.18.1 OVERVIEW
12.18.2 SWOT ANALYSIS
12.18.3 PRODUCT PORTFOLIO
12.18.4 REVENUE ANALYSIS
12.18.5 ANALYSTS VIEW
12.19 AMEDICA CORPORATION
12.19.1 OVERVIEW
12.19.2 SWOT ANALYSIS
12.19.3 PRODUCT PORTFOLIO
12.19.4 REVENUE ANALYSIS
12.19.5 ANALYSTS VIEW
12.20 ATLAS APINE
12.20.1 OVERVIEW
12.20.2 SWOT ANALYSIS
12.20.3 PRODUCT PORTFOLIO
12.20.4 REVENUE ANALYSIS
12.20.5 ANALYSTS VIEW
13 APPENDIX
14 ABOUT DATA BRIDGE MARKET RESEARCH
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Related Reports: